Abstract
During 2003–2004, locally presenting pleural empyema cases in children increased 3-fold. Antigen analysis of empyema fluid identified Streptococcus pneumoniae in 27 of 29 cases for whom samples were available and capsular polysaccharide type 1 in 18 of these. Use of a conjugate vaccine without serotype 1 antigen would have had limited impact on this morbidity in our region.
| Translated title of the contribution | Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine |
|---|---|
| Original language | English |
| Pages (from-to) | 559 - 560 |
| Number of pages | 2 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 25 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2006 |
Bibliographical note
Publisher: Lippincott Williams & WilkinsOther: (on behalf of the South West of England Invasive Community acquired Infection Study Group
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Empyema, Pleural
- Humans
- Child
- Immunity
- Pneumococcal Infections
- Great Britain
- Risk Assessment
- Age Distribution
- Child, Preschool
- Vaccines, Conjugate
- Streptococcus pneumoniae
- Pneumococcal Vaccines
- Prospective Studies
- Antibodies, Bacterial
- Enzyme-Linked Immunosorbent Assay
- Incidence
- Follow-Up Studies
- Female
- Male
Fingerprint
Dive into the research topics of 'Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver